Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Acquisitions (2017 - 2023)

Varex Imaging (VREX) reported Acquisitions of -$900000.0 for Q4 2023, down 190.0% on a QoQ basis from $1.0 million in Q3 2023.

Varex Imaging (VREX) has 5 years of Acquisitions data on file, last reported at -$900000.0 in Q4 2023.

  • Quarterly Acquisitions changed N/A year-over-year to -$900000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$900000.0 (down 190.0% YoY) and the FY2024 annual result came in at -$900000.0, down 190.0% from the prior year.
  • Acquisitions fell to -$900000.0 in Q4 2023 per VREX's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $69.5 million in Q2 2019 and bottomed at -$900000.0 in Q4 2023.
  • The 3-year median for Acquisitions is $1.0 million (2023), against an average of $14.2 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Varex Imaging 419.42 Mn 345.02 Mn 72.60 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 29, 2023 -900,000.00
Sep 29, 2023 1.00 Mn
Oct 2, 2020 400,000.00
Jan 3, 2020 1.20 Mn
Jun 28, 2019 69.50 Mn
Sep 28, 2018 4.80 Mn
Sep 29, 2017 -4.20 Mn